Voyager Acquisition Corp Cl A (VACH)

$10.02 +0.01 (0.10%)
Market Cap 0.00
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 319,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K 50%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Voyager Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to focus on businesses in the healthcare or healthcare related sectors. The company was incorporated in 2023 and is based in Brooklyn, New York.

Industry: Shell Companies
Sector: Financial Services
Phone: 347 720 2907
Address:
131 Concord Street, Brooklyn, United States
PenkeTrading
PenkeTrading May. 3 at 12:56 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Voyager Acquisition Corp. Is that bullish or bearish? $VACH #RsiOverbought #NASDAQ
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Apr. 23 at 9:28 PM
$VACH strikes a $1.3B deal to merge with Veraxa Biotech, aiming to list as VERX on Nasdaq. Promising tech in next-gen cancer therapies, but execution risk remains high with 900+ oncology competitors. SPAC math: $253M trust cash meets Phase 1 pipeline. Let's see if the market buys the BiTAC story. https://www.sec.gov/Archives/edgar/data/2006815/000182912625002874/voyageracq_8k.htm
0 · Reply
swingingtech
swingingtech Apr. 23 at 6:35 AM
$VERX $VACH $XLS https://wallstreetwaves.com/veraxa-biotech-and-voyager-acquisition-corp-announce-business-combination-to-advance-next-gene
0 · Reply
BulldogTheDip
BulldogTheDip Feb. 6 at 4:56 PM
$VACH Picked up this SPAC at 10.11
1 · Reply
Latest News on VACH
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

May 29, 2025, 6:34 PM EDT - 27 days ago

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

May 20, 2025, 12:10 PM EDT - 5 weeks ago

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Aug 8, 2024, 10:24 PM EDT - 11 months ago

Voyager Acquisition Corp. Announces Pricing of $220,000,000 Initial Public Offering

Healthcare SPAC Voyager Acquisition files for a $261 million IPO

Jun 18, 2024, 4:48 PM EDT - 1 year ago

Healthcare SPAC Voyager Acquisition files for a $261 million IPO

Voyager Acquisition IPO Registration Document (S-1)

Jun 18, 2024, 4:21 PM EDT - 1 year ago

Voyager Acquisition IPO Registration Document (S-1)

PenkeTrading
PenkeTrading May. 3 at 12:56 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Voyager Acquisition Corp. Is that bullish or bearish? $VACH #RsiOverbought #NASDAQ
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Apr. 23 at 9:28 PM
$VACH strikes a $1.3B deal to merge with Veraxa Biotech, aiming to list as VERX on Nasdaq. Promising tech in next-gen cancer therapies, but execution risk remains high with 900+ oncology competitors. SPAC math: $253M trust cash meets Phase 1 pipeline. Let's see if the market buys the BiTAC story. https://www.sec.gov/Archives/edgar/data/2006815/000182912625002874/voyageracq_8k.htm
0 · Reply
swingingtech
swingingtech Apr. 23 at 6:35 AM
$VERX $VACH $XLS https://wallstreetwaves.com/veraxa-biotech-and-voyager-acquisition-corp-announce-business-combination-to-advance-next-gene
0 · Reply
BulldogTheDip
BulldogTheDip Feb. 6 at 4:56 PM
$VACH Picked up this SPAC at 10.11
1 · Reply